Qingwen Lyu

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 1

Top Topics

Chronic Kidney Disease

Peritoneal Dialysis

Inflammatory Response

Top Venues

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Weimei Huang, Anqi Lin, Peng Luo, Yuchen Liu, Wentao Xu, Weiliang Zhu, Ting Wei, Qingwen Lyu, Linlang Guo, Jian Zhang
EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma. Cancer gene therapy 28 (7-8) (2020)